Updated 23 weeks ago
Stress-Induced Hormone Imbalances Go Far Beyond Insulin in Diabetes
Brenda Neugent |
Feb 3, 2014 |
Virtually anything from the stress of a long checkout line to the first signs of menopause can trigger hormone imbalances, which reveal themselves through mood swings, fatigue, migraines, memory problems, and a lackluster sex drive.
FDA Gives Long-Awaited Nod to Amylin’s Bydureon
Diabetes Health Staff |
Feb 3, 2012 |
After several years of delays and setbacks, Amylin Pharmaceuticals has received FDA approval to begin US marketing of BydureonTM. The first once-a-week type 2 therapy to be offered in the US market, Bydureon is expected to be available by February. Amylin says that its wholesale price will be about $4,200 a year.
Fatal error: Call to a member function getUrl() on a non-object in /home/diabetes/public_html/browse.php on line 54